A detailed history of Pathstone Holdings, LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 49,262 shares of MDXG stock, worth $454,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,262
Previous 81,732 39.73%
Holding current value
$454,688
Previous $566,000 48.59%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$5.65 - $7.76 $183,455 - $251,967
-32,470 Reduced 39.73%
49,262 $291,000
Q2 2024

Aug 14, 2024

SELL
$6.16 - $8.08 $129,507 - $169,873
-21,024 Reduced 20.46%
81,732 $566,000
Q1 2024

May 13, 2024

BUY
$7.61 - $8.63 $494,330 - $560,587
64,958 Added 171.86%
102,756 $791,000
Q4 2023

Feb 14, 2024

BUY
$5.7 - $9.14 $215,448 - $345,473
37,798 New
37,798 $331,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.05B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.